Expressions of Interest (EOI) are invited from paediatric precision medicine research teams seeking to use the subsidised services of the Luminesce Alliance Functional Genomics Enabling Platform.
The Luminesce Alliance Functional Genomics Enabling Platform delivers new research capacity across stem cell medicine and vectorology, intensifiying collaboration, research translation and end-to-end commercialisation and competitive advantages. The platform is one of five Luminesce Alliance Enabling Platforms. Read more
The EOI is open to Luminesce Alliance partner organisations (Sydney Children’s Hospitals Network, Children’s Medical Research Institute, Children’s Cancer Institute, University of NSW, University of Sydney). For full criteria read more